{
  "case_id": "case_0046",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 30.46,
    "sex": "Male",
    "genderIdentity": "Transgender Male",
    "ancestry": "South Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, Neurosyphilis, Compressive Optic Neuropathy, TB and Retinal Detachment.\n\nOther possible differentials:\n- SLE and Bartonella.\n- Also feasible but of low probability: Beh\u00e7et's, Lyme, Lymphoma, Vasculitis, Sjogren's and Leber's Hereditary Optic Neuropathy.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Non-arteritic anterior ischaemic optic neuropathy (atypical for age, usually > 50)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Typical demyelinating optic neuritis associated with multiple sclerosis",
          "Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis",
          "Aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting with optic neuritis",
          "Compressive optic neuropathy (e.g., optic nerve sheath meningioma, pituitary or suprasellar mass)",
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Infectious or systemic inflammatory optic neuropathy (e.g., sarcoidosis, syphilis, tuberculosis, HIV-associated)",
          "Macular or retinal pathology causing unilateral visual loss"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Compressive_Optic_Neuropathy",
          "CNS_Tuberculosis",
          "Syphilis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "MOGAD",
          "Retinal_Detachment"
        ],
        "missing_lesion_dx_keys": [
          "Bartonella_Henselae",
          "Idiopathic_Optic_Neuritis",
          "Behcet_Disease",
          "Infection_Lyme",
          "CNS_Lymphoma",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "Autoimmune_Myelitis_SLE",
          "Optic_Neuropathy_Nonspecific",
          "Leber_Hereditary_Optic_Neuropathy"
        ],
        "missing_common_names": [
          "Bartonella",
          "SLE"
        ],
        "missing_low_prob_names": [
          "Beh\u00e7et's",
          "Lyme",
          "Lymphoma",
          "Vasculitis",
          "Sjogren's",
          "Leber's Hereditary Optic Neuropathy"
        ],
        "additional_diagnoses": [
          "Non-arteritic anterior ischaemic optic neuropathy"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 1,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 18,
        "lesion_ddx_matched_count": 8,
        "lesion_ddx_missed_common_count": 2,
        "lesion_ddx_missed_low_prob_count": 6,
        "lesion_ddx_coverage_percentage": 0.4444444444444444
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, anti-AQP4, ENA, ACE, HIV, ANCA, syphilis, ESR.\n- Could also consider testing: anti-dsDNA, bartonella, TB, lyme, CSF (flow cytometry and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium contrast and fat-suppressed sequences",
          "Formal visual field testing (e.g., Humphrey perimetry)",
          "Optical coherence tomography of retinal nerve fibre layer and macula",
          "Colour vision testing (e.g., Ishihara plates)",
          "Visual evoked potentials",
          "Slit-lamp and dilated fundus examination by ophthalmology",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Serum vitamin B12",
          "Serum folate",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Antineutrophil cytoplasmic antibody",
          "Serum angiotensin-converting enzyme level",
          "Serum aquaporin-4 IgG antibody",
          "Serum myelin oligodendrocyte glycoprotein IgG antibody",
          "Serum syphilis serology (treponemal and non-treponemal tests)",
          "HIV antigen/antibody test",
          "Chest X-ray",
          "Lumbar puncture for cerebrospinal fluid cell count, protein, glucose, oligoclonal bands, and IgG index"
        ],
        "all_identified_ft_keys": [
          "MRI_Brain",
          "MOG_Antibodies",
          "CRP",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "OCT",
          "Chest_XRay",
          "Folate",
          "Colour Vision",
          "Ophthalmology Assessment",
          "HIV_Test",
          "Serum_Immunoglobulins",
          "VEP",
          "ANCA",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Bartonella_Serology",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "Bartonella_Serology",
          "TB_Screen",
          "CSF_Cytology",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 10,
        "ddx_tests_coverage_percentage": 0.625
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Symptoms started more than 14 days\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone (e.g., 1 g daily for 3 days) followed by a short oral prednisolone taper",
            "timing": "Start Now",
            "reasons": [
              "Typical age and phenotype for inflammatory demyelinating optic neuritis with significant unilateral visual loss",
              "High-dose corticosteroids accelerate visual recovery and reduce acute inflammation even when started within weeks of onset",
              "Can be commenced promptly once urgent MRI excludes a compressive or abscess-like lesion and basic infection screening is reassuring"
            ]
          },
          {
            "treatment": "Proton pump inhibitor and gastric protection while on high-dose steroids",
            "timing": "Start Now",
            "reasons": [
              "Reduces risk of steroid-induced gastritis or peptic ulcer disease",
              "Standard prophylaxis for short courses of high-dose systemic corticosteroids in otherwise healthy adults"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for multiple sclerosis according to local guidelines",
            "timing": "Delay",
            "reasons": [
              "Initiation depends on MRI and cerebrospinal fluid findings demonstrating dissemination in space and/or time consistent with multiple sclerosis",
              "Requires detailed counselling regarding risks, benefits, monitoring, and choice of specific agent"
            ]
          },
          {
            "treatment": "Plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserved for severe optic neuritis, particularly in aquaporin-4 or MOG antibody-associated disease, that fails to improve after high-dose corticosteroids",
              "Invasive therapy with significant resource and risk implications, only justified once standard steroid therapy has been ineffective"
            ]
          },
          {
            "treatment": "Targeted treatment of alternative causes of optic neuropathy (e.g., intravenous penicillin for syphilis, corticosteroids or other immunosuppression for sarcoidosis, neurosurgical or ophthalmic decompression for compressive lesions)",
            "timing": "Delay",
            "reasons": [
              "Specific therapy depends entirely on investigation results identifying a non-demyelinating aetiology",
              "Avoids unnecessary or potentially harmful treatments until a definite alternative diagnosis is established"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone (e.g., 1 g daily for 3 days) followed by a short oral prednisolone taper",
            "timing": "Start Now",
            "reasons": [
              "Typical age and phenotype for inflammatory demyelinating optic neuritis with significant unilateral visual loss",
              "High-dose corticosteroids accelerate visual recovery and reduce acute inflammation even when started within weeks of onset",
              "Can be commenced promptly once urgent MRI excludes a compressive or abscess-like lesion and basic infection screening is reassuring"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Safety screen for contraindications like active infection is required before immunosuppression."
              ],
              "contraindications": [
                "Symptoms started more than 14 days"
              ]
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Symptoms started more than 14 days"
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for multiple sclerosis according to local guidelines",
            "timing": "Delay",
            "reasons": [
              "Initiation depends on MRI and cerebrospinal fluid findings demonstrating dissemination in space and/or time consistent with multiple sclerosis",
              "Requires detailed counselling regarding risks, benefits, monitoring, and choice of specific agent"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        }
      }
    }
  }
}